Bob Silverman

Bob Silverman

Consultant / Advisor at
The New York City Investment Fund Manager, Inc.
Finance
Consumer Services
Commercial Services

Profile

Bob A. Silverman currently works at The New York City Investment Fund Manager, Inc., as Advisor and C2i Genomics, Inc., as Chief Business Officer from 2023.
Mr. Silverman also formerly worked at Biohealth Innovation, Inc., as Director, Roche Holding AG, as Venture Capital Lead from 2012 to 2020, Pennie & Edmonds LLP, as Associate, Alloy Therapeutics LLC, as Executive Partner & Chief Business Officer from 2019 to 2021, and Rejuveron Life Sciences AG, as Chief Business Officer from 2021 to 2022.
Mr. Silverman received his undergraduate degree from Franklin & Marshall College and graduate degree from Boston University School of Law.

Bob Silverman active positions

CompaniesPositionStart
Consultant / Advisor -
Corporate Officer/Principal 31/12/2022

Former positions of Bob Silverman

CompaniesPositionEnd
Corporate Officer/Principal 30/11/2022
Corporate Officer/Principal 30/06/2021
ROCHE HOLDING AG General Counsel 30/12/2003
Corporate Officer/Principal 30/12/1993
Director/Board Member -
See the detail of Bob Silverman's experience

Training of Bob Silverman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

63

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Commercial Services

Consumer Services

Finance

Consumer Services

Finance

Commercial Services

Technology Services

Finance